MedTrace Logo

Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes

NCT00809575 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 927

Last updated 2020-12-22

No results posted yet for this study

Summary

RATIONALE: Gathering information about quality of life, fatigue, and other symptoms from patients with myelodysplastic syndromes may help doctors learn more about the disease and may help plan treatment.

PURPOSE: This clinical trial is studying quality of life and symptoms in patients with newly diagnosed myelodysplastic syndromes.

Conditions

Interventions

OTHER

questionnaire administration

OTHER

fatigue assessment and management

OTHER

observation

OTHER

quality-of-life assessment

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Fabio Efficace, PhD · Gruppo Italiano Malattie EMatologiche dell'Adulto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-02
Primary Completion
2018-10-08
Completion
2021-02-28

Countries

  • United States
  • Austria
  • Belgium
  • Brazil
  • China
  • Croatia
  • Czechia
  • France
  • Germany
  • Italy
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809575 on ClinicalTrials.gov